Compounds > bay y3118
Page last updated: 2024-09-03

bay y3118 and Bacterial Infections

bay y3118 has been researched along with Bacterial Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldridge, KE1
Finegold, SM; Molitoris, E; Wexler, HM1

Other Studies

2 other study(ies) available for bay y3118 and Bacterial Infections

ArticleYear
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones

1994
In vitro activity of Bay Y3118 against anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:11

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones

1993